Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
|Active Ingredient:||Polatuzumab vedotin 140mg|
|Dosage Form:||Powder for injection|
|New Zealand Sponsor:||Roche Products (NZ) Limited|
|Manufacturer:||BSP Pharmaceuticals SpA, Latina, Italy|
|Note: This consent is valid for two years from the date of publication of this notice.|
Dated this 19th day of December 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).